Fisher & Paykel Webinar: Nasal High Flow Use During a Pandemic: Implication for Clinical Practice

Fisher and Paykel Healthcare will be holding a Webinar on Nasal High Flow Use During a Pandemic: Implications for Clinical Practice on Wednesday 28th April 2021 at 6pm AEST/8pm NZST.

Further information on the program can be found below:

Moderator
Dr Stephen Warrillow 
Director of Intensive Care, Austin Health
Immediate Past President, ANZICS

Speakers
Associate Prof. Dr Jie Li
Associate Professor, Rush University, Chicago, USA
Topic: Risk of bio-aerosolisation with NHF therapy

Prof. Gerard Criner
Professor, Thoracic Medicine and Surgery, Temple University, Philadelphia, USA
Topic: HFN therapy for Hypoxemic Respiratory Failure in COVID-19

Please follow this link to view the flyer and to register.